Wikidata

(Q33347913)

English

Phase I clinical and pharmacokinetic study of E7070, a novel sulfonamide given as a 5-day continuous infusion repeated every 3 weeks in patients with solid tumours. A study by the EORTC Early Clinical Study Group (ECSG)

scientific article published on May 1, 2003

In more languages
default values for all languages
No label defined

No description defined

Statements

title
Phase I clinical and pharmacokinetic study of E7070, a novel sulfonamide given as a 5-day continuous infusion repeated every 3 weeks in patients with solid tumours. A study by the EORTC Early Clinical Study Group (ECSG) (English)
1 reference
stated in
Crossref
DOI
10.1016/S0959-8049(03)00128-X
reference URL
https://api.crossref.org/works/10.1016/S0959-8049(03)00128-X
retrieved
31 December 2023
author name string
EORTC Early Clinical Study Group
series ordinal
9
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12736109
retrieved
26 July 2017
cites work

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q33347913&oldid=2143377582"